Literature DB >> 25351987

Structural basis of clade-specific HIV-1 neutralization by humanized anti-V3 monoclonal antibody KD-247.

Karen A Kirby1, Yee Tsuey Ong1, Atsuko Hachiya1, Thomas G Laughlin1, Leslie A Chiang1, Yun Pan1, Jennifer L Moran1, Bruno Marchand1, Kamalendra Singh1, Fabio Gallazzi2, Thomas P Quinn3, Kazuhisa Yoshimura4, Toshio Murakami5, Shuzo Matsushita6, Stefan G Sarafianos7.   

Abstract

Humanized monoclonal antibody KD-247 targets the Gly(312)-Pro(313)-Gly(314)-Arg(315) arch of the third hypervariable (V3) loop of the HIV-1 surface glycoprotein. It potently neutralizes many HIV-1 clade B isolates, but not of other clades. To understand the molecular basis of this specificity, we solved a high-resolution (1.55 Å) crystal structure of the KD-247 antigen binding fragment and examined the potential interactions with various V3 loop targets. Unlike most antibodies, KD-247 appears to interact with its target primarily through light chain residues. Several of these interactions involve Arg(315) of the V3 loop. To evaluate the role of light chain residues in the recognition of the V3 loop, we generated 20 variants of KD-247 single-chain variable fragments with mutations in the antigen-binding site. Purified proteins were assessed for V3 loop binding using AlphaScreen technology and for HIV-1 neutralization. Our data revealed that recognition of the clade-specificity defining residue Arg(315) of the V3 loop is based on a network of interactions that involve Tyr(L32), Tyr(L92), and Asn(L27d) that directly interact with Arg(315), thus elucidating the molecular interactions of KD-247 with its V3 loop target. © FASEB.

Entities:  

Keywords:  HIV; crystal structure; entry; single-chain variable fragment

Mesh:

Substances:

Year:  2014        PMID: 25351987      PMCID: PMC4285544          DOI: 10.1096/fj.14-252262

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  67 in total

1.  DICHROWEB, an online server for protein secondary structure analyses from circular dichroism spectroscopic data.

Authors:  Lee Whitmore; B A Wallace
Journal:  Nucleic Acids Res       Date:  2004-07-01       Impact factor: 16.971

2.  Ex vivo neutralization of HIV-1 quasi-species by a broadly reactive humanized monoclonal antibody KD-247.

Authors:  Shuzo Matsushita; Soichiro Takahama; Junji Shibata; Tetsuya Kimura; Koichi Shiozaki; Yasuyuki Eda; Atsushi Koito; Toshio Murakami; Kazuhisa Yoshimura
Journal:  Hum Antibodies       Date:  2005

3.  Structure of antibody F425-B4e8 in complex with a V3 peptide reveals a new binding mode for HIV-1 neutralization.

Authors:  Christian H Bell; Ralph Pantophlet; André Schiefner; Lisa A Cavacini; Robyn L Stanfield; Dennis R Burton; Ian A Wilson
Journal:  J Mol Biol       Date:  2007-11-13       Impact factor: 5.469

4.  Postinfection passive transfer of KD-247 protects against simian/human immunodeficiency virus-induced CD4+ T-cell loss in macaque lymphoid tissue.

Authors:  Toshio Murakami; Yasuyuki Eda; Tadashi Nakasone; Yasushi Ami; Kenji Someya; Naoto Yoshino; Masahiko Kaizu; Yasuyuki Izumi; Hajime Matsui; Katsuaki Shinohara; Naoki Yamamoto; Mitsuo Honda
Journal:  AIDS       Date:  2009-07-31       Impact factor: 4.177

5.  Computed circular dichroism spectra for the evaluation of protein conformation.

Authors:  N Greenfield; G D Fasman
Journal:  Biochemistry       Date:  1969-10       Impact factor: 3.162

6.  Antibody neutralization and escape by HIV-1.

Authors:  Xiping Wei; Julie M Decker; Shuyi Wang; Huxiong Hui; John C Kappes; Xiaoyun Wu; Jesus F Salazar-Gonzalez; Maria G Salazar; J Michael Kilby; Michael S Saag; Natalia L Komarova; Martin A Nowak; Beatrice H Hahn; Peter D Kwong; George M Shaw
Journal:  Nature       Date:  2003-03-20       Impact factor: 49.962

7.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

8.  Expression, purification, and isotope labeling of the Fv of the human HIV-1 neutralizing antibody 447-52D for NMR studies.

Authors:  Naama Kessler; Anat Zvi; Min Ji; Michal Sharon; Osnat Rosen; Rina Levy; Miroslaw Gorny; Suzan Zolla-Pazner; Jacob Anglister
Journal:  Protein Expr Purif       Date:  2003-06       Impact factor: 1.650

9.  Human immunodeficiency virus type 1 evasion of a neutralizing anti-V3 antibody involves acquisition of a potential glycosylation site in V2.

Authors:  Makiko Hatada; Kazuhisa Yoshimura; Shigeyoshi Harada; Yoko Kawanami; Junji Shibata; Shuzo Matsushita
Journal:  J Gen Virol       Date:  2009-12-23       Impact factor: 3.891

Review 10.  Achieving a cure for HIV infection: do we have reasons to be optimistic?

Authors:  Valentin Le Douce; Andrea Janossy; Houda Hallay; Sultan Ali; Raphael Riclet; Olivier Rohr; Christian Schwartz
Journal:  J Antimicrob Chemother       Date:  2012-02-01       Impact factor: 5.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.